| Term 
 | Definition 
 
        | 1. Penicillin 2. cephalosporin 3. carbapenems & monobactams 4. Vancomycin 5. Vancomycin Alternatives: Linezolid, quinupristin/dalfopristin, daptomycin, telavancin  6. Fluroquinolones |  | 
        |  | 
        
        | Term 
 
        | Penicillin CLassification |  | Definition 
 
        | -narrow spectrum penicillin (natural penicillins)   -Penicilinase-Resistant penicillins  (Anti-staph penicillins)   -Extended spectrum penicillins (Amino-penicillins, anti-pseudomonal penicillin, B-lactamase inhibitor combinations) - |  | 
        |  | 
        
        | Term 
 
        | Narrow Spectrum Penicillins (Natural Penicillins) |  | Definition 
 
        | Penicillin G-IV, IM, PO Penicillin V-PO |  | 
        |  | 
        
        | Term 
 
        | Spectrum of activity of Penicillins |  | Definition 
 
        | Gram + (Steptococcus, Enterococcus) Gram - (Neisseria meningitidis) Anaerobes (peptostreptococcis, clostridiium non-deficil) Other (troponema pallidum, listeria) |  | 
        |  | 
        
        | Term 
 
        | Common use of penicillins: |  | Definition 
 
        | 1. Step pharynitis 2. strep pneumoniae infections 3. endocarditis due to strept viridans 4. endocarditis prophylaxis 5. meningitis due to neisseria meningtidis 6. Syphilis=DOC 7. Lymes disease (carditis, meningitis, arthritis, high dose) |  | 
        |  | 
        
        | Term 
 
        | benzathine pen procaine pen benzathine/procaine penicillin Penicillin G potassium or sodium Penicillin V potassium |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dose for strep pharyngitis |  | Definition 
 
        | Penicillin V potassium PO 500 mg BID x 10days |  | 
        |  | 
        
        | Term 
 
        | Methicillin nafcillin oxacillin Dicloxacillin cloxacillin |  | Definition 
 
        | Penicillinase-resistance penicillins |  | 
        |  | 
        
        | Term 
 
        | Spectrum of activity of penicillinase-resistant penicillins |  | Definition 
 
        | G+ (MSSA, streptococcus, MSSE) Anaerobes (Peptostreptococcus) |  | 
        |  | 
        
        | Term 
 
        | Common uses of penicillinase resistant penicillin |  | Definition 
 
        | 1.Skin and skin structures infections due to stap areus (MSSA, or MSSE)   2.osteomyelitis dues to MSSA or MSSE   3.Infection of prosthetic joint due to MSSA or MSSE   4.Line infections due to staph   |  | 
        |  | 
        
        | Term 
 
        | Nafcillin and oxacillin dicloxacillin |  | Definition 
 
        | Penicillinase Resistant penicillins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Extended Spectrum Penicillins   Amino-penicillins |  | 
        |  | 
        
        | Term 
 
        | Spectrum of activity for amino-penicillins |  | Definition 
 
        | G+ = streptococcus, enterococcus G- = H.flu, Neisseria, proteus Anaerobes = Peptostreptococcus, clostridium (non deficil)   Other = listeria, H.pylori |  | 
        |  | 
        
        | Term 
 
        | Common use of Amino-penicillins |  | Definition 
 
        | 1.Upper respiratory tract infections -otitis media (amoxicillin DOC) -Strep pharyngitis (strep pyogenes) 2. enterococcus infection 3. UTI 4. Meningtits due to listeria monocytogenes 5. H. pylori (with PPI and other abx) 6. Lymes disease     |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amoxicillin/clavulanate (augmentin) Ampicillin/sulbactam (Unasyn) |  | Definition 
 
        | Amino-penicillin + B lactamase inhibitor |  | 
        |  | 
        
        | Term 
 
        | Amino-penicillins + B lactamase inhibitor spectrum of activity |  | Definition 
 
        | G+ = Staph, Strep, Enterococcus G- = H.flu, neisseria, m.cat, E.coli, Klbsiella, proteus anaerobes = peptostreptococcus, clostridium, B.fragilis   |  | 
        |  | 
        
        | Term 
 
        | Common uses of Amino-Penicillins + b-lactamase inhibitor |  | Definition 
 
        | Otitis media Sinusitis aspiration pneumonia Bites (cat, dog, human) Urinary tract infections Anearobic infections (abscess) |  | 
        |  | 
        
        | Term 
 
        | Amoxicillin/clavulanate (augmentin)   Ampicillin Ampicillin/sulbactam |  | Definition 
 
        | Amino-Penicillins + B-lactamase inhibitor |  | 
        |  | 
        
        | Term 
 
        | Ticarcillin Piperacillin Carbenicillin Mezlocillin |  | Definition 
 
        | Anti-pseudomonal penicillin |  | 
        |  | 
        
        | Term 
 
        | Anti-pseudomonal penicillins spectrum of activity |  | Definition 
 
        | G+ = Staph, Step, enterococcus G- = h. flu, neisseria, m.cat, e.coli, klebsiella, proteus, pseudomonas Anaerobes = peptostreptocuccus, clostridium, B. fragilis   Broadest spectrum |  | 
        |  | 
        
        | Term 
 
        | Common uses of anti-pseudomonal penicillins + B-lactamase inhibitor |  | Definition 
 
        | 1. Ticacillin and piperacillin are rarely used w/out B-lactamase inhibitors 2. Empiric broad spectrum coverage +/- other antimicrobials -Gi organisms: ruptured appy, gi surgery, diverticulitis -nosocomial pneumonia (hospital aquired) 3. Pseudomonas infections 4. febrile neutropenia |  | 
        |  | 
        
        | Term 
 
        | Zosyn (piperacillin/tozobactam) timentin (ticarcillin/clavulanate) |  | Definition 
 
        | Anti-pseudomonal penicillins + B-lactamase inhibitors |  | 
        |  | 
        
        | Term 
 
        | Adverse effects: Penicillin |  | Definition 
 
        | Generally well tolerated Allergic rxn: rash, anaphylaxis, increased LFts, interstitial nephritis Amox/Amp: Maculopapular rash with mono infection, CLLL, allopurinol= not true allergy diarrhea seizures with high doses neutropenia, thrombocytopnia thrombophlebitis   |  | 
        |  | 
        
        | Term 
 
        | clinical issues of penicillins |  | Definition 
 
        | 1. Dose changed for renal dysfunction 2. strep pneumo more resistant to pen 3. time above MIC is critical to penicillins success -frequent doses -continues infusion pen have to be used |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bind to PSPs and interfere with cell wall synthesis- similar to PEN |  | 
        |  | 
        
        | Term 
 
        | Mechanism of resistance of cephalosporins: |  | Definition 
 
        | -B-lactamase production (Cephs are more stable with b-lactamse) -PEn binding protein alteration |  | 
        |  | 
        
        | Term 
 
        | Cephalosporin Classification: |  | Definition 
 
        | Separated into 3 generations   1st generation = G+ best (G-worst) no anaerobes 3rd generation = G- best (G+worst)   All cephalosporins dont work against MRSA and enterococcus |  | 
        |  | 
        
        | Term 
 
        | Cephalexin (keflex)   Cefazolin (ancef, kefzol)   |  | Definition 
 
        | 1st generation cephalosporins |  | 
        |  | 
        
        | Term 
 
        | Common use of 1st cephalosporin |  | Definition 
 
        | Skin and skin structure infections bone infections surgical prophylaxis uncomplicated UTI (EKP)   |  | 
        |  | 
        
        | Term 
 
        | cefuroxime (ceftin) cefoxitin (mefoxin) |  | Definition 
 
        | 2nd generation cephalosporins   Spectrum of activity in the middle g+ g- anaerobes |  | 
        |  | 
        
        | Term 
 
        | Common uses of 2nd generation cephalosporins |  | Definition 
 
        | Respiratory tract infections otitis media UTI, cystitis, pyelonephritis cefoxitin & cefotetan only-GI, GU, GYN, procedures, and tx pelvic inflammatory disease w/doxycycline |  | 
        |  | 
        
        | Term 
 
        | PO:  Cefpodoxime (vantin) cefdinir (omnicef)   Iv: Ceftriaxone (rocephin), cefotamime (claforan), cefizoxime (cefizox), ceftazidime (fortaz), cefipime (maxipime)     |  | Definition 
 
        | 3rd generation cephalosporin   Spectrum activity G+ G- |  | 
        |  | 
        
        | Term 
 
        | Common use of 3rd generation cephalosporins |  | Definition 
 
        | PO agents -respiratory tract infections UTI   IV agents Empiric tx of serious infections Meningitis DOC w/ vancomycin W/aminoglycoside for pseudomonas febrile neutopenia |  | 
        |  | 
        
        | Term 
 
        | Adverse effects: Cephalosporins |  | Definition 
 
        | 1.Generally well tolerated 2.hypersensitivity -cross reactivity with penicillin -do not use with hives to penicillin 3.diarrhea 4. neutropenia, throbocytopenia 5. platelet dysfunction   |  | 
        |  | 
        
        | Term 
 
        | DOC for N. gonorrhea Useful in otitis media   Need double coverage for pseudomonas |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | imipenem + cilastatin (primaxin) meropenem (merrem) doripenem (doribax) ertapenem (invanz)   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mechanism of resistance with carbapenems |  | Definition 
 
        | generally stable in the presence of most types of b-lactamase   pseudomonas has shown altered permeability to imipenem   antagonism has been seen when imipenem is use with other b-lactams due to inc B-lactamase production |  | 
        |  | 
        
        | Term 
 
        | Spectrum of activity for carbapenems |  | Definition 
 
        | G+ G- (good) Anaerobes (good) |  | 
        |  | 
        
        | Term 
 
        | Common Uses of carbapenems and monbactams |  | Definition 
 
        | - Serious nosocomial infections (hospital acquired) -serious polymicrobial infections -intra-abdominal infections (hospital acquireD) -pseudomonoas infections -febrile neutropenia |  | 
        |  | 
        
        | Term 
 
        | The other carbapenem   +spectrum of activity |  | Definition 
 
        | Ertapenem   Similar to imipenem but no psuedomonas or enterococcis coverage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intra-abdominal infections Skin and skin structures infections UTI, pyelonephritis |  | 
        |  | 
        
        | Term 
 
        | Adverse effects of Carbapenems   |  | Definition 
 
        | Allergy - rash   Seizures-do not use with hx of seizures of meningitis   GI problems |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Monobactams:  mechanisms of action |  | Definition 
 
        | Similar to other B-lactams binds to PBPs and therefore inhibits call wall formation |  | 
        |  | 
        
        | Term 
 
        | Spectrum of activity of monobactams |  | Definition 
 
        | considered a g-specialist good activity against G- aerobes including pseudomonas |  | 
        |  | 
        
        | Term 
 
        | Common uses of monobactams |  | Definition 
 
        | G- sepsis urinary tract infection G- osteomyelitis G- pneumonia intra-abdominal infections CF (inhaled) |  | 
        |  | 
        
        | Term 
 
        | vancomycin spectrum of activity |  | Definition 
 
        | G+ very active Staph, MRSA, MRSE -DOC; Strep, Enterococcus |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of vancomycin |  | Definition 
 
        | Inhibits bacterial cell wall synthesis at earlier step than the b-lactams |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PEN, carbs, cephs, and slightly aztreonam |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of vancomycin |  | Definition 
 
        | 1.Not absorbed from GI 2.Given IV for systemic infections 3.diffuses well into pleural, pericardial, synovial and ascitic fluids 4.therapeutic levels inCSF occur only with inflamed meninges and high doses 5.half-life 6hr with normal renal function upto 7.5 days with renal impairment 6. is not removed by conventional dialysis but is removed by high-flux methods of HD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  DOC: HCA-MRSA MRSE, and enterococci (for PNC-allergy)   serious infections caused by s.aureus, enterococcus, or strep intolerant of b-lactams   infections caused by g+ organisms   clostridiium defficile colitis if metronidazole fails   endocarditid prophylaxis- GU or GI procedures in PEN intolerant pts   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neohrotixicity ototoxicity red man/neck syndrome |  | 
        |  | 
        
        | Term 
 
        | VANC resistant enterococcus |  | Definition 
 
        | VRE 15% OF ICU STRAINS   4 serotypes: 1. VanA type- High level resitence 2. VanB type- resistent to vanco 3. VanC type-low level resistance to vanco only 4. VanD type-similar to VanB   |  | 
        |  | 
        
        | Term 
 
        | VANCO resistance prevention |  | Definition 
 
        | Vanco is discouraged in: -prophylaxis for infection or colonization of vasc catheters -eradication of MRSA colonization or CA-MSRA -primary tx for clostridium difficile colitis -routine prophylaxis for very low birth weight infanst -routine prophylaxis for peritoneal dialysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1.Healthcare associated: Vanco =DOC or daptomysin   2. Community-associated MRSA = TMP/SMX, clindamycin, doxyclcline         |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Linezolid, quinupristin/dalfopristin, daptomycin,telavancin |  | 
        |  | 
        
        | Term 
 
        | Linezolid MOA, Spectrum of activity, and use |  | Definition 
 
        | moa: protein synthesis inhibitor   Spectrum: Staph, strep, enterococcus, resistant organisms   Use: should be strictly reserved to serious infections due to organisms resistant to other therapies   |  | 
        |  | 
        
        | Term 
 
        | QUINUPRISTIN/DALFOPRISTIN   info: |  | Definition 
 
        | MOA: protein synthesis inhibitor combo Spectrum: staph, step, enter, resistant organisms, VRE   Use: should be reserved for serious infections |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits bacterial cell wall synthesis Spectrum: gram-positive bacteria, including MRSA   Use: strictly reserved to serious infections |  | 
        |  | 
        
        | Term 
 
        | Strictly reserved for serious infections |  | Definition 
 
        | 1. Linezolid 2. Quinupristin/dalfopristin 3.telavancin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits topoisomerases II (supercoil DNA) and IV (separates daughter from parent)   Inhibition of topoisomerases results in rapid and lethal cessation of DNA replication |  | 
        |  | 
        
        | Term 
 
        | Mechanism of resistance of fluroquinolones |  | Definition 
 
        | Efflux pump gene mutation permeability |  | 
        |  | 
        
        | Term 
 
        | ciprofloxacin (cipro) ofloxacin (floxin) norfloxacin (norflox) |  | Definition 
 
        | Second generation Fluoroquinolones g- best |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Third generation fluoroquinolones |  | 
        |  | 
        
        | Term 
 
        | Moxifloxacin (avelox) Gemifloxacin (factive) |  | Definition 
 
        | Fourth generation fluoroquinolones   g+ best |  | 
        |  | 
        
        | Term 
 
        | Fluoroquinolones- spectrum |  | Definition 
 
        | Other bacteria: -chlamydia -legionella -mycoplasma -mycobacterium TB, Avium -H. Pylori: with combo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | best psuedomonal activity of quinolones, poor s. pneumoniae   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Better S. pneumoniae than cipro, but ledd than 4th generation   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | best respiratory quinolones |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | UTI (pyelonephritis, cystitis, prostatitis) Osteomyelitis due to gram - CAP M. tuberculosis complicated gram- and anaerobic abdominal and gyn infections |  | 
        |  | 
        
        | Term 
 
        | Overuse of quinolones in: |  | Definition 
 
        | acute exacerbations of chronic bronchitis chronic sinusitis travelers diarrhea |  | 
        |  | 
        
        | Term 
 
        | Adverse effects of quinolones: |  | Definition 
 
        | limited in children under 18 and avoided in pregnancy =bone/joint erosion in young animals   -gi problems   -cns -dizzy, headache |  | 
        |  | 
        
        | Term 
 
        | Drug interactions of quinolones |  | Definition 
 
        | chelation (dec absorption) theophylline (cipro) warfarin avoid with meds that prolong QT interval |  | 
        |  |